Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis
Public ClinicalTrials.gov record NCT00192517. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of MEDI-522, a Humanized Monoclonal Antibody to Integrin Alpha V Beta 3, Administered by Subcutaneous Injection to Adults With Plaque Psoriasis
Study identification
- NCT ID
- NCT00192517
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- MedImmune LLC
- Industry
- Enrollment
- 44 participants
Conditions and interventions
Conditions
Interventions
- MEDI-522 Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2003
- Primary completion
- Jul 31, 2004
- Completion
- Aug 31, 2004
- Last update posted
- Apr 2, 2009
2003 – 2004
United States locations
- U.S. sites
- 18
- U.S. states
- 15
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Bressinck, Gibson, Parker, Dinehart, Sanster Dermatology, PA | Little Rock | Arkansas | 72205 | — |
| Associates In Research, Inc. | Fresno | California | 93710 | — |
| Solano Dermatology Associates | Vallejo | California | 94589 | — |
| Dermatology Specialists | Vista | California | 92083 | — |
| The Savin Center, P.C. | New Haven | Connecticut | 06511-4808 | — |
| North Florida Dermatology Associates, P.A. | Jacksonville | Florida | 32204 | — |
| Atlanta Dermatology, Vein & Research Center, LLC | Alpharetta | Georgia | 30005 | — |
| South Bend Clinic | South Bend | Indiana | 46617 | — |
| FutureCare Studies, INC | Springfield | Massachusetts | 01107 | — |
| Midwest Cutaneous Research, Corp. | Clinton Township | Michigan | 48038 | — |
| Central Dermatology | St Louis | Missouri | 63117 | — |
| Karen Harkaway, M.D., LLC | Riverside Park | New Jersey | 08075 | — |
| University of Cincinnati | Cincinnati | Ohio | 45219 | — |
| NorthEast Clinical Research Centers, Inc | Allentown | Pennsylvania | 18103 | — |
| Clincial Partners, LLC | Johnston | Rhode Island | 02919 | — |
| Harmony Clinical Research | Johnson City | Tennessee | 37601 | — |
| Tenn. Clinical Research Center, INC | Nashville | Tennessee | 37215 | — |
| Derm. Clinical Research Center of San Antonio | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00192517, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 2, 2009 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00192517 live on ClinicalTrials.gov.